CASI: CASI Pharmaceuticals, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 39.66
Enterprise Value ($M) 42.25
Book Value ($M) 13.85
Book Value / Share 0.89
Price / Book 2.86
NCAV ($M) -2.62
NCAV / Share -0.17
Price / NCAV -15.16

Profitability (mra)
Return on Invested Capital (ROIC) -0.89
Return on Assets (ROA) -0.41
Return on Equity (ROE) -1.28

Liquidity (mrq)
Quick Ratio 2.32
Current Ratio 3.20

Balance Sheet (mrq) ($M)
Current Assets 47.15
Assets 63.62
Liabilities 49.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
10-29 13G/A Huang James 9.20 26.99
08-12 13D/A He Wei-Wu 20.94 14.80
07-25 13G Venrock Healthcare Capital Partners III, L.P. 9.99
06-20 13G Foresite Capital Fund VI LP 9.80
02-20 13D/A Sparkle Byte Ltd 7.60 -90.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-23 4,862 14,112 34.45
2025-01-22 9,404 50,073 18.78
2025-01-21 11,301 22,595 50.02

(click for more detail)

Similar Companies
CALC – CalciMedica, Inc. CAPR – Capricor Therapeutics, Inc.
CARA – Cara Therapeutics, Inc. CDIO – Cardio Diagnostics Holdings, Inc.
CDMO – Avid Bioservices, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.